Kwon H. Hong, Ph.D. - Publications

Affiliations: 
2014 Medicinal Chemistry University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Therapeutics Discovery & Development

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Faber EB, Wang N, John K, Sun L, Wong HL, Burban D, Francis R, Tian D, Hong KH, Yang A, Wang L, Elsaid M, Khalid H, Levinson NM, Schönbrunn E, et al. Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice. Journal of Medicinal Chemistry. PMID 36701569 DOI: 10.1021/acs.jmedchem.2c01731  0.475
2021 Lee JC, Hong KH, Becker A, Tash JS, Schönbrunn E, Georg GI. Tetrahydroindazole inhibitors of CDK2/cyclin complexes. European Journal of Medicinal Chemistry. 214: 113232. PMID 33550184 DOI: 10.1016/j.ejmech.2021.113232  0.462
2020 Zhou Y, Hu Y, Lu X, Yang H, Li Q, Du C, Chen Y, Hong KH, Sun H. Discovery of a Selective 6-Hydroxy-1, 4-Diazepan-2-one Containing Butyrylcholinesterase Inhibitor by Virtual Screening and MM-GBSA Rescoring. Dose-Response : a Publication of International Hormesis Society. 18: 1559325820938526. PMID 32636723 DOI: 10.1177/1559325820938526  0.379
2020 Syeda SS, Sánchez G, McDermott JP, Hong KH, Blanco G, Georg GI. The Na+ and K+ transport system of sperm (ATP1A4) is essential for male fertility and an attractive target for male contraception†. Biology of Reproduction. PMID 32588885 DOI: 10.1093/Biolre/Ioaa093  0.447
2019 Wang Y, Yang Y, Hong KH, Ning Y, Yu P, Ren J, Ji M, Cai J. Design, synthesis and evaluation of a novel metal chelator as multifunctional agents for the treatment of Alzheimer's disease. Bioorganic Chemistry. 87: 720-727. PMID 30954836 DOI: 10.1016/J.Bioorg.2019.03.064  0.387
2018 Yang F, He CP, Diao PC, Hong KH, Rao JJ, Zhao PL. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 30448234 DOI: 10.1016/J.Bmcl.2018.11.024  0.389
2018 Zhou B, Hong KH, Ji M, Cai J. Design, Synthesis and Biological Evaluation of Structurally Constrained Hybrid Analogues Containing Ropinirole Moiety as a Novel Class of Potent and Selective Dopamine D3 Receptor Ligands. Chemical Biology & Drug Design. PMID 29710404 DOI: 10.1111/Cbdd.13324  0.333
2018 Syeda SS, Sánchez G, Hong KH, Hawkinson JE, Georg GI, Blanco G. Design, Synthesis, in vitro and in vivo Evaluation of Ouabain Analogs as Potent and Selective Na,K-ATPase α4 Isoform Inhibitors for Male Contraception. Journal of Medicinal Chemistry. PMID 29291372 DOI: 10.1021/Acs.Jmedchem.7B00925  0.472
2017 Chen Y, Zhu JY, Hong KH, Mikles DC, Georg GI, Goldstein AS, Amory JK, Schönbrunn E. Structural basis of ALDH1A2 inhibition by irreversible and reversible small molecule inhibitors. Acs Chemical Biology. PMID 29240402 DOI: 10.1021/Acschembio.7B00685  0.515
2017 Diao PC, Li Q, Hu MJ, Ma YF, You WW, Hong KH, Zhao PL. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties. European Journal of Medicinal Chemistry. 134: 110-118. PMID 28410492 DOI: 10.1016/J.Ejmech.2017.04.011  0.419
2016 Ranade AR, Higgins L, Markowski TW, Glaser N, Kashin D, Bai R, Hong KH, Hamel E, Höfle G, Georg GI. Characterizing the Epothilone Binding Site on β-Tubulin by Photoaffinity Labeling: Identification of β-Tubulin Peptides TARGSQQY and TSRGSQQY as Targets of an Epothilone Photoprobe for Polymerized Tubulin. Journal of Medicinal Chemistry. PMID 26986898 DOI: 10.1021/Acs.Jmedchem.6B00188  0.44
2015 Cai J, Wei H, Hong KH, Wu X, Zong X, Cao M, Wang P, Li L, Sun C, Chen B, Zhou G, Chen J, Ji M. Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents. Bioorganic & Medicinal Chemistry. 23: 3457-71. PMID 25953722 DOI: 10.1016/J.Bmc.2015.04.028  0.427
2015 Cai J, Wei H, Hong KH, Wu X, Cao M, Zong X, Li L, Sun C, Chen J, Ji M. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors. European Journal of Medicinal Chemistry. 96: 1-13. PMID 25874326 DOI: 10.1016/J.Ejmech.2015.04.002  0.424
2015 Cai J, Liu L, Hong KH, Wang P, Li L, Cao M, Sun C, Wu X, Zong X, Chen J, Ji M. Discovery of phenoxybutanoic acid derivatives as potent endothelin antagonists with antihypertensive activity. Bioorganic & Medicinal Chemistry. 23: 657-67. PMID 25614116 DOI: 10.1016/J.Bmc.2015.01.003  0.357
2014 Cai J, Li L, Hong KH, Wu X, Chen J, Wang P, Cao M, Zong X, Ji M. Discovery of 4-aminoquinazoline--urea derivatives as Aurora kinase inhibitors with antiproliferative activity. Bioorganic & Medicinal Chemistry. 22: 5813-23. PMID 25270403 DOI: 10.1016/J.Bmc.2014.09.029  0.418
2012 Niphakis MJ, Gay BC, Hong KH, Bleeker NP, Georg GI. Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs. Bioorganic & Medicinal Chemistry. 20: 5893-900. PMID 22910225 DOI: 10.1016/J.Bmc.2012.07.044  0.542
2006 Duvvuri M, Konkar S, Hong KH, Blagg BS, Krise JP. A new approach for enhancing differential selectivity of drugs to cancer cells. Acs Chemical Biology. 1: 309-15. PMID 17163760 DOI: 10.1021/Cb6001202  0.355
Show low-probability matches.